Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,493 across all filing types
Latest filing 2022-07-20 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
募集资金管理制度（2022年7月修订）
Governance Information Classification · 95% confidence The document is titled '募集资金管理制度（修订稿）' which translates to 'Fundraising Capital Management System (Revised Draft)'. It details the management, storage, usage, supervision, and regulatory compliance related to the company's raised funds. The content is a comprehensive policy or internal regulation document about fundraising capital management, including references to laws, regulatory requirements, and internal procedures. It is not a financial report, earnings release, or announcement of voting results. It is not a presentation or transcript. It is a regulatory or compliance document outlining internal rules and governance practices related to fundraising capital. Therefore, the document best fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2022-07-20 Chinese
股东大会议事规则(2022年7月修订)
Governance Information Classification · 95% confidence The document is titled '股东大会议事规则' which translates to 'Rules of Procedure for the Shareholders' General Meeting' of Tian Kang Biological Co., Ltd. It details the procedures, legal basis, and regulations governing the convening, proposal submission, notification, and conduct of shareholders' meetings. It includes references to Chinese company law, securities law, and regulatory requirements. The content is focused on governance and procedural rules for shareholder meetings rather than reporting financial results, voting outcomes, or announcements of meetings. It is not a report of the meeting itself, nor an announcement of voting results or a proxy solicitation. The document is a governance-related document outlining internal rules and practices for shareholder meetings. Therefore, the most appropriate classification is Governance Information (CGR). The document length (7608 characters) and detailed procedural content support this classification with high confidence.
2022-07-20 Chinese
内部控制制度
Governance Information Classification · 95% confidence The document is titled as an "Internal Control System" of Tian Kang Biological Co., Ltd. It extensively details the company's internal control policies, risk management, governance structure, control activities, and procedures related to financial reporting, information disclosure, related party transactions, external guarantees, fundraising usage, major investments, and internal control evaluation and reporting. The document is comprehensive and regulatory in nature, focusing on internal control mechanisms rather than financial results or management changes. It does not present financial statements or earnings data, nor is it a brief announcement or a certification. It is a detailed governance-related report about internal controls and their implementation, evaluation, and disclosure. This fits best under the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices, including internal control systems.
2022-07-20 Chinese
关联交易决策制度(2022年7月修订)
Governance Information Classification · 95% confidence The document is titled '关联交易决策制度' which translates to 'Related Party Transaction Decision System' and contains detailed internal rules and procedures regarding related party transactions, including definitions, decision-making processes, disclosure requirements, and governance principles. It references relevant laws and stock exchange regulations, indicating it is a governance or internal control document rather than a financial report or announcement. There is no indication of financial statements, audit results, earnings data, or meeting minutes. The document is a policy or governance framework related to related party transactions, which fits best under Governance Information (CGR). The document length (6527 characters) supports it being a full policy document rather than a brief announcement or notice.
2022-07-20 Chinese
总经理工作细则
Governance Information Classification · 95% confidence The document is titled '总经理工作细则' which translates to 'General Manager Work Rules' or 'General Manager Operating Procedures'. It details the roles, responsibilities, and authority of the general manager and other senior management personnel within the company. It includes sections on the general provisions, powers of the general manager, meeting procedures, and other internal governance matters. There is no financial data, no mention of financial results, no audit information, no voting results, no legal proceedings, no capital changes, or any other typical financial or regulatory filing content. The document is a governance-related internal policy document, focusing on management roles and procedures. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 3888 characters, which is consistent with a detailed governance policy document rather than a brief announcement or a full annual report. Hence, the classification is CGR with high confidence.
2022-07-20 Chinese
内幕信息知情人登记制度(2022年7月修订）
Governance Information Classification · 95% confidence The document is titled '内幕信息知情人登记管理制度' which translates to 'Insider Information Insider Registration Management System' and is issued by 天康生物股份有限公司 (Tiankang Biological Co., Ltd.). The content is a detailed internal regulatory policy document about the management, registration, confidentiality, and responsibilities related to insider information and insider persons. It references relevant laws and regulatory bodies such as the China Securities Regulatory Commission and Shenzhen Stock Exchange. The document is a governance and compliance policy rather than a financial report, earnings release, or announcement. It does not contain financial statements, earnings data, or voting results. It is a governance-related internal rules document about insider information management and compliance. Therefore, the most appropriate classification is Governance Information (CGR). The document length (8382 characters) supports it being a full policy document rather than a short announcement or certification.
2022-07-20 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.